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0022-2836 © 2007 Elsevier Ltd. Open acceSeveral heavy chain isoforms of class II myosins are found in muscle fibres
and show a large variety of different mechanical activities. Fast myosins
(myosin heavy chain (MHC)-II-2) contract at higher velocities than slow
myosins (MHC-II-1, also known as β-myosin) and it has been well
established that ADP binding to actomyosin is much tighter for MHC-II-1
than for MHC-II-2. Recently, we reported several other differences
between MHC-II isoforms 1 and 2 of the rabbit. Isoform II-1 unlike II-2
gave biphasic dissociation of actomyosin by ATP, the ATP-cleavage step
was significantly slower for MHC-II-1 and the slow isoforms showed the
presence of multiple actomyosin–ADP complexes. These results are in
contrast to published data on MHC-II-1 from bovine left ventricle muscle,
which was more similar to the fast skeletal isoform. Bovine MHC-II-1 is
the predominant isoform expressed in both the ventricular myocardium
and slow skeletal muscle fibres such as the masseter and is an important
source of reference work for cardiac muscle physiology. This work
examines and extends the kinetics of bovine MHC-II-1. We confirm the
primary findings from the work on rabbit soleus MHC-II-1. Of significance
is that we show that the affinity of ADP for bovine masseter myosin in the
absence of actin (represented by the dissociation constant KD) is weaker
than originally described for bovine cardiac myosin and thus the
thermodynamic coupling between ADP and actin binding to myosin is
much smaller (KAD/KD∼5 instead of KAD/KD∼50). This may indicate a
distinct type of mechanochemical coupling for this group of myosin
motors. We also find that the ATP-hydrolysis rate is much slower for
bovine MHC-II-1 (19 s−1) than reported previously (138 s−1). We discuss
how this work fits into a broader characterisation of myosin motors from
across the myosin family.© 2007 Elsevier Ltd. Open access under CC BY license. Edited by M. Moody Keywords: subfragment 1; actin; ATPase; strain-sensor; ADPIntroduction
The myosin superfamily consists of at least 18
classes of ATP-dependent motor proteins that
interact with actin filaments and are involved in aess:
n heavy chain; MLC,
light chain; ELC,
fragment S1; BMS1,
S1; BCS1, bovine
A, trichloroacetic
ss under CC BY license. large variety of physiological processes, such as
muscle contraction, phagocytosis, cell motility and
vesicle transport.1,2 Class II myosins (found in
muscle) consist of two heavy chains (MHC) and
two pairs of light chains: the regulatory light chains
(RLC) and essential light chains (ELC). The C
termini of the myosin heavy chains dimerize and
form a coiled-coil (“myosin tail”) whereas the N-
termini form the two myosin “heads” or “motor-
domains”. The most familiar activity of class II
myosins is muscle contraction. All myosins appear
to undergo the same ATP driven cycle of interaction
of myosin with actin, known as the cross-bridge
cycle, yet myosins show a wide variety of different
mechanical activities. We are interested in the
variety of different types of mechanochemical
1185Bovine Masseter Myosinactivities shown both within and between the
members of the myosin family.
Myosins from fast contracting, anaerobic, muscle
fibres are amongst the best characterized myosins
with events of the biochemical cross-bridge cycle
having been correlated with mechanical and struc-
tural data from contracting muscle fibres. These fast
myosins comprise a subgroup of the myosins family
known as MHC-II-2 with three primary isoforms
found in the mammalian adult skeletal muscle, 2a,
2b and 2x, each expressed from a different gene.3
The isoform MHC-II-1 is found in slow, aerobic
skeletal muscle fibres and in ventricular cardiac
muscle tissue where it is known as MHC-β. The
myosin light chains (MLC) also differ between
myosins with muscle-specific isoforms of both
light chains.4 Whereas a single regulatory light
chain isoform (MLC2s) is found in both the slow
skeletal muscle and in the ventricle of mammals that
have been examined, there are two isoforms of slow
muscle essential light chains. One is found pre-
dominantly in the adult slow skeletal and the
ventricle muscle (called MLC-1s/v or MLC-1s/b).
The other (MLC-1sa) predominates in smooth and
non-muscle tissue and in some skeletal muscle
during development.5 The MLC-1s/b is larger and
includes and anN-terminal extension, rich in proline
and lysine. Unlike molluscan and smooth muscle
myosins, where light chain phosphorylation and
calcium binding are the primary regulators of
myosin's activity, the light chains of striated muscles
seem to have relatively little effect on enzymatic
activity of the isolated myosin head.6 However, the
presence of specific light chain isoforms and their
removal does have substantial effects on the
generation of force and motility by striated myosin.6
The MLC stabilise the lever-arm or neck of the
myosin head and they are in a position to modulate
the translation of the isomerisation of the head into
mechanical force or movement.7
Fast muscle fibres containing the MHC-II-2, as
their name suggests, contract at higher velocities
and are more susceptible to fatigue than slow
muscle fibres containing MHC-II-1 and both proper-
ties have been related to the properties of the myosin
heavy chain isoform expressed in the muscle. It is
well established that ADP binding to actomyosin is
much tighter for MHC-II-1 (slow isoform) than for
MHC-II-2 (fast isoform).8 We recently examined the
solution biochemical kinetic properties of the slow
isoform MHC-II-1 from rabbit soleus muscle and
compared it to the well characterised fast isoform
MHC-II-2 from rabbit psoas muscle.9 This showed
several significant differences between the two
isoforms including:
(1) Unlike MHC-II-2, the MHC-II-1 gave biphasic
dissociation of actomyosin by ATP.
(2) The tight binding of ADP to actomyosin was con-
firmed for MHC-II-I with at least three conforma-
tions of actomyosin–ADP present in equilibrium.
(3) The rate constant for ADP release from the
predominant actomyosin–ADP complex wasthe correct size to limit the shortening velocity
of MHC-II-1 containing soleus muscle fibres.
(4) MHC-II-1 has a significantly reduced rate con-
stant for the ATP hydrolysis step.
Together these results indicate that the kinetic
differences between the fast and slow MHC-II
isoforms are greater than at first expected and that
MHC-II-1 has much in common with some of the
much slower smooth and non-muscle myosins (see
Discussion).
Three of the above novel observations (numbers
(1), (2) and (4)) were in contrast to published data on
the same isoform isolated from bovine ventricle
muscle. Bovine MHC-II-1 has been widely studied
from cardiac ventricle tissue and is an important
source of reference work for cardiac muscle phy-
siology.8,10 It is therefore essential to test if the
differences observed between the rabbit and bovine
isoforms are due to the experimental differences or
species differences. The previous studies on bovine
cardiac S1 (BCS1) reported that the ATP-hydrolysis
rate is much higher (k+3+k-3=138 s
−1)11,12 than the
hydrolysis rate reported for rabbit soleus S1 under
similar conditions (RSS1, k+3+k-3=22 s
−1).9 Also,
unlike RSS1, the ATP-induced dissociation of AM, in
the presence or absence of ADP, could not be fitted
unambiguously to two components.10 In order to
address these differences we used bovine MHC-II-1
isolated from the slow, bovine masseter muscle.
Bovine masseter muscle is large, easily accessible
and contains N95% MHC-II-1, which makes it con-
venient for large scale biochemical preparations.13
This tissue is readily available and the isolated
myosin and S1 are stable when stored at −20 °C. In
order to further examine potential species differ-
ences we also isolated myosin S1 from pig soleus
fibres as another source of MHC-II-1 myosin. This
tissue is not as pure in myosin isoform content14 but
does provide a second reference material. Masseter
muscle fibres have a maximum shortening velocity
(V0=0.27 μm s
−1) of 40% of the value for rabbit
soleus fibres (V0=0.67 μm s
−1) at 12 °C13 whereas
the pig soleus fibres are even slower (V0=0.17 μm
s−1).13,15 SinceV0 has been shown to be a property of
the MHC isoform, the species differences in the
isoforms used here are expected to be significant.
The work presented here confirms the primary
finding from the work of rabbit soleus, and extends
these studies to slow bovine and porcine myosins.
Of significance is that we show that the affinity of
ADP for bovine masseter myosin is weaker than
originally described for bovine cardiac myosin and
thus the thermodynamic coupling between ADP
and actin binding to myosin is much smaller10,11
(KAD/KD ∼5 instead of KAD/KD∼50). This may
indicate a distinct type of mechanochemical cou-
pling for this group of myosin motors. We also find
that the ATP-hydrolysis rate is much slower for
BMS1 (19 s−1) than reported previously for BCS1
(138 s−1).
We discuss how this work fits into a broader
characterization of myosin motors from across the
1186 Bovine Masseter Myosinmyosin family. Indeed the relevance of our observa-
tions on the significant differences between fast and
slow muscle myosin isoforms in the release of ADP
has been underlined by a recent study by Iwamoto
et al.,16 published as we submitted this work. They
have shown, using a novel X-ray scattering ap-
proach, that slow muscle acto––S1 has a distinct
movement of the lever arm on binding ADP,
whereas little movement was detected with a fast
muscle isoform. Larger movements were observed
with the S1 from smooth and non-muscle myosin II
isoforms. These observations are consistent with
earlier electron micrograph images of ADP induced
movements of the lever arm of smooth muscle17 and
cytoplasmic myosin from the wider myosin family,
such as myosin I18 and myosin VI.19 Thus, biochem-
ical and structural studies are coming together to
define how ADP release is a key event in defining
the mechano-chemical coupling of different types of
myosin.Results
Nucleotide binding to BMS1 in the absence of
actin
MHC-II-1 myosin was purified from bovine
masseter muscle fibres (see Materials and Methods).
Figure 1 shows the isolated myosin with two light
chains and the purified BMS1 with only one light
chain bound. The binding of ATP or ADP to myosin
S1 is characterised by an increase in intrinsic protein
fluorescence associated with nucleotide binding.Figure 1. SDS–polyacrylamide electrophoresis gel of
BMS1 purification. Samples were run on a SDS–15% gel
with glycine/Tris/SDS running buffer. Lane 1, bovine
masseter myosin (BMMyosin) with two light chains. Lane
2, BMS1 after chymotrypsin digestion and column pur-
ification. Lane 3, molecular mass marker.Figure 2(a) shows the fluorescence change observed
on rapidly mixing 25 μMor 400 μMATPwith 0.5 μM
BMS1 at 20 °C (concentrations are post mixing). At
25 μM the transient increase in fluorescence (ΔF)
shown can be satisfactorily described by a two
exponential function with kobs=19.6 s
−1 (ΔF +11.8%)
and 2.5 s−1 (ΔF +4%). The fast phase is easily
separated from the slower component and at low
ATP concentrations (b50 μM) appears linearly
dependent on ATP concentration with an apparent
second-order rate constant of 0.97×106 M−1s−1. At
higher ATP concentrations the kobs value saturates
and a hyperbolic fit to the data gives a K0.5 value of
56 μM with a kmax of 117 s
−1 (Figure 2(b)). The slow
phase only appears as a single process at low ATP
concentrations (≤50 μM); at higher ATP there
appear to be two components. Separating out
these two phases across the full range of ATP
concentrations is problematic but at ATP concentra-
tions above 50 μM, the data can all be described by a
small slow phase of amplitude 1–1.5% with a kobs of
2 s−1 and a medium rate phase with kobs of 12-15 s
−1
and an amplitude of 4%. This is illustrated in Figure
2(a) for [ATP]=400 μM where the transient increase
in fluorescence (ΔF) shown can be satisfactorily
described by a triple exponential function (with
kobs=111 s−1 (ΔF +10%), kobs=13.5 s
−1 (ΔF +3.7%)
and kobs=2 s
−1 (ΔF +1%) for the fast, medium and
slow phase, respectively). The analysis of the data
shown in Figure 2(b) has been fitted assuming a
constant slow phase of 2 s−1. The medium phase
process at 12–15 s−1 is then only apparent when the
fast component is faster than ∼30 s−1 and then
appears to be constant. In order to rule out
contamination with ADP as the cause of the slower
phases, BMS1 was extensively treated with apyrase
but this had little effect on the observed transients.
The K0.5 and kmax of the fast phase can be assigned
to K1 and k+2 of Scheme 1, respectively, the steps
that control ATP binding as observed for many
other myosin isoforms. One of the two slower
phases could be due to the ATP hydrolysis step of
ATP (k+3+k-3 in Scheme 1) that is known to generate
changes in fluorescence for other myosins as des-
cribed.20,21 In order to determine what is being
observed here, quench flow measurements were
done in order to establish the rate of ATP hydrolysis.
BMS1 (5 μM) was mixed with excess ATP (50 μM)
and incubated at 20 °C for desired time intervals (up
to 350 ms). Figure 3 shows a rapid initial burst of
ADP production, which can be described by a single
exponential function with kobs of 19 s−1 and an
amplitude of 0.61 ADP/S1. The amount of irrever-
sibly bound ATP to BMS1 at the end of the burst was
determined by quenching the reaction into a
hexokinase/glucose buffer after 1 s and then adding
6.5% trichloroacetic acid (TCA) after a further 1 s. In
controls this treatment hydrolysed any free ATP to
ADP. After HPLC analysis of the reaction mixture
0.14 ATP/S1 remained and therefore at the end of
the burst phase 0.14 ATP/S1 remains as tightly
bound M*.ATP and 0.61 ADP/S1 as M**.ADP.Pi
(Scheme 1). Thus the value of K3= [M.ADP.Pi]/ [M*.
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fast muscle S1.22,23 The value of the kobs can be
assigned to k+3+k-3 and at 19 s
−1 is similar to the
medium phase of the stopped-flow fluorescence
transient (kobs=15 s
−1). Thus, as for other myosins
the hydrolysis step is accompanied by a fluorescence
change. It is worth noting that this is quite a slow
process, compared to the hydrolysis rate for fast
skS1 from rabbit, which is tenfold faster, but similar
to the hydrolysis rate for the slow myosin S1 from
rabbit or pig soleus muscle9 (see Table 1). The origin
of the slowest component of the fluorescence tran-
sient remains to be defined. This is small (1–1.5%)
and has a constant kobs value of 2 s
−1. This could
arise from a small fraction of damaged myosin, from
a contaminant myosin or from a fraction of the
myosin that must isomerise before ATP can bind to it
(see Discussion of ATP binding to actomyosin). TheFigure 2. Rate of association of ATP or ADP with
BMS1. (a) The protein fluorescence changes observed on
mixing 0.5 μM BMS1 with 25 μM ATP or 400 μM ATP at
20 °C. For the reaction with 25 μMATP the best-fit double
exponential is superimposedwith kobs=19.6 s
−1 (ΔF+11.8%)
and 2.5 s−1 (ΔF +4%) for the fast and medium/slow
phase, respectively. The fluorescence of the reaction with
400 μM ATP could best be fitted to a triple exponential
with kobs=111 s
−1 (ΔF +10%), kobs=13.5 s
−1 ((ΔF +3.7%)
and kobs=2 s
−1 (ΔF +1%) for the fast, medium and slow
phase, respectively. (b) Dependence of kobs on ATP
concentration. At high ATP-concentrations, kobs saturates
at 117 s−1 for the fast phase (▪), at 18 s−1 for the mediumphase (•) and 2.0 s−1 for the slow phase (▴). At low ATP
concentrations the data fit a straight line with slope
(K1k+2)=1.5×10
6 M−1s−1 for the fast phase. (c) Depen-
dence of kobs on ADP concentration, with a saturation
value for kobs=26 s
−1. The maximal rate of ADP-binding
represents k+6 +k-6 (kmax,ADP)=26 s
−1 and K7=K0.5,ADP=
21 μM. The intercept yields k+6 (=k-D)=1.4(±0.5) s−1. The
second-order constant of ADP binding k-6/K7 (=k+D) is
defined by kmax,ADP/K0.5,ADP=1.24×106 M−1s−1, resulting
in KD (k-D/k+D)=1.2 μM.signals are very weak and represent a small fraction
of the total making it very difficult to investigate and
we have not pursued this further. Arrhenius plots of
the maximal observed rates of the fast phase (k+2)
and the medium phase (k+3+k-3) and van 't Hoff plot
of K1 (not shown) show that between 8 °C–20 °C K1
does not depend on temperature. k+2 and k+3+k-3
have a marked temperature dependence with
similar activation energies of 71 kJ/mol and 75 kJ/
mol, respectively. The ratio of the amplitudes for the
fast and medium phase remains fairly constant
between 8 °C–20 °C (ratio∼4:1).
The rate of ADP-association with BMS1 was also
measured. In this case the fluorescence increase was
smaller (ΔF 3%) than seen for ATP. There was no
evidence of a slow component of the reaction and
the transient increase in fluorescence could be fitted
to a single exponential. At high ADP concentrations
kobs reaches a maximum value of 26 s
−1 when fitted
to a hyperbola (Figure 2(c)). The ADP-release rate
k+6 (=k-D) can be determined from the intercept,
k+6=1.4(±0.5) s
−1. The maximal rate of ADP-bind-
ing represents k+6+ k-6 (kmax,ADP)=26 s
−1 and
K7=K0.5,ADP=21 μM. The second-order constant of
ADP binding k-6/K7 (or k+D) can be defined by
kmax,ADP/K0.5,ADP=1.24×10
6M-1s−1 (see also Table 1)
from which a value for the equilibrium dissociation
constant can be calculated: KD (1/K6K7)=1.2 μM.
Repeating the ADP-binding experiment using the
slow myosin S1 isolated from pig soleus muscle,
PSS1, showed that this myosin S1 had a slightly
tighter affinity for ADP (KD=0.9 μM; see Table 1).
An alternative method of determining k+6 (or k-D)
is the displacement of ADP from BMS1 by addition of
an excess ATP. Figure 4(a) and (b) shows the reaction
observed on adding 100 μM ATP to 0.5 μM BMS1 in
the presence of 0.2 μM ADP. The best fit of the
fluorescence changes is the sum of three exponen-
tials with kobs of 68 s
−1, 9.6 s−1 and 1.1 s−1. Two of the
observed three phases are due to the binding of ATP
Scheme 1. Proposed reaction scheme for the interaction of BMS1 with nucleotides (T, ATP; D, ADP) as described.43
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(9.6 s−1), as described above, and the third phase, the
binding of ATP, is limited by ADP release from
BMS1-ADP (see Figure 4(a) and (b)), with an ADP-off
rate of 1.1 s−1. Using a triphasic fit the observed rate
constants are fairly independent of ADP concentra-
tion (average rate constants for the fast, medium and
slow phase are 75 s−1, 8 s−1 and 0.9 s−1, respectively)
but the measured amplitudes depend on the ADP
concentrations. The amplitude of the fast phase
(ATP-binding to BMS1) and medium phase (ATP-
hydrolysis) decrease and of the slow phase (ADP
dissociation) increases as the ADP concentration is
increased (Figure 4(c)). The relative ratio of the
amplitudes for the fast and medium phase remain
constant up to 2 μM ADP (Afast: Amedium∼4: 1). At
higher ADP concentrations the amplitude of the
ATP hydrolysis process, Amedium, becomes very
small but the observed rate constant, kobs, is not
affected by [ADP]. In order to be able to separate
Afast and Amedium at high ADP concentrations, the
relative ratio Afast/Amedium was fixed at 4. The ADP
dependence of the amplitudes could be described by
hyperbolas with independent best-fit dissociation
constants of 2.6 μM (fast phase), 3.0 μM (medium
phase) and 3.0 μM (slow phase), resulting in anFigure 3. Kinetics of MgATP hydrolysis by BMS1 using
rapid quench-flow at 20 °C (100 mM KCl, 20 mM Mops,
5 mMMgCl2(pH 7)). 5 μM
BMS1 is first mixed with 50 μM
MgATP and after variable time quenched with 6.25% TCA
The ADP/total nucleotide ratio is plotted as a function of
time and can be fitted to a single exponential, resulting in a
time constant t for the initial burst (t=52ms), resulting in a
kobs of 19 s
−1.average KD=2.8 μM. This is in reasonable agreement
with the value found previously using the ADP
binding experiment in Figure 2 (KD=1.2 μM) andwe
will use the median value of 2.0. A tighter affinity of
ADP for the S1 product of bovine cardiac MHC-1
myosin was reported (KD=0.33 μM) when the
interaction of ATP and ADP with bovine cardiac
S1 was investigated.11
Nucleotide binding to MHC1 myosin S1 in the
presence of actin
The ATP-induced dissociation of acto–MHC-1
complexes can be followed by monitoring the
fluorescence of a pyrene label covalently attached
to Cys374 of actin. At ATP concentrations above
100 μM, the ATP-induced dissociation of bovine
masseter myosin S1 (BMS1) is biphasic, as is illus-
trated in Figure 5(a) and (b), whereas below 100 μM
ATP the fluorescence can be fitted to a single
exponential. Figure 5(a) shows the resulting change
in fluorescence upon mixing 0.5 μM pyrene-labelled
acto–BMS1 complex with 200 μM ATP. At this ATP
concentration the reaction can be best described by a
double exponential with kobs=278 s
−1 (ΔF 77%) and
58 s−1 (ΔF 10%) for the fast and the slow phase,
respectively. The fast phase shows a hyperbolic
dependence on [ATP] and saturates at kobs=900–
1100 s−1 whereas the slow phase remains constant at
56(±13) s−1 at [ATP]N100 μM (Figure 5(b)). The rate
constant of the slow phase (kslow=56 s
−1) is similar to
the rate constant of ADP-release (94 s−1) and one
could argue it is possible that the slow phase is due
to contamination with ADP. However, prolonged
incubation of BMS1 with apyrase did not remove the
slow phase. The presence of another myosin isoform
contamination might also cause the biphasic beha-
vior. Bovine masseter fibres are not 100% MHC-1β
but contain a small amount (5%) of MHC-1α isoform
but this is a fast isoform and is therefore unlikely to
cause an additional slow phase.13 The presence of
non-muscle myosins (either class 2 or others) could
produce a slow phase but the amplitude of the slow
phase (15%) is far too large to come from such a
source. For BMS1, according to scheme II, the kobs for
the slow phase observed here can be assigned to
k+α=56 s−1. From the ratio of the amplitudes of the
fast and slow phase of ATP-induced acto–BMS1
dissociation (77:10) the value of Kα=7.7, can be
assigned. Since Kα=k+α/k-α and k+α=56 s
−1 then
Table 1.Comparison of the rate and equilibrium constants for the interaction of S1 myosins with nucleotides at 20 °C and
100 mM KCl (pH 7.0)
Parameter S1(bovine)a masseter S1 (rabbit)b fast skeletal S1 (bovine)c,d cardiac S1 (rabbit)e soleus S1 (pig)a soleus
K1k+2 (10
6 M−1s−1) 0.97 1.9 0.81d 1.57 –
k+2 (s
−1) 117 N1000j 138i 191 –
k+3+k-3 (s
−1) 18 131 12/138i 21.6 24h.5h
k+6 (k-D) (s
−1) 0.9f–1.4g 1.4 0.5 0.61 0.84
k-6/K7 (k+D) (10
6 M−1s−1) 1.24g 1.5 1.4 1.5 –
KD (μM) 1.2
g–2.8f 2 0.33 0.41 0.5–1.4
a This study.
b From Ritchie et al.45
c From Flamig & Cusanovich.11
d From Smith & Cusanovich.12
e From Iorga et al.9
f From ADP-displacement data (Figure 4).
g From ADP+S1 association experiment (Figure 2(c)).
h Pig cardiac S1.24
i The observed rate of 138 s−1, originally assigned to k+3 +k-3, actually represents k+2 (see Discussion).
j From Miller & Greeves.20
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−1. The temperature-dependence of the
ATP-induced dissociation of acto–BMS1 was mea-
sured between 8 °C −32 °C at a low ATP-concentra-
tion (50 μM). From the dependence of kobs on
temperature the activation energy can be calculated
as Ea=22 kJmol
−1 (not shown).
The effect of ADP on the dissociation rate constant
was measured at two different ATP concentrations:
[ATP]=50 μM and [ATP]=200 μM. At [ATP]=
50 μM, the ATP-induced dissociation of 0.5 μM
pyrene-labelled acto–BMS1, pre-incubated with 0–
250 μM ADP, yielded a fluorescence change of 55%
that could be fitted to a single exponential. The
resulting kobs was plotted against ADP concentra-
tion (see Figure 6(a)) and fitting against equation (4)
resulted in a KAD of 9.6(±1.4) μM. Presuming the on-
rate is diffusion- limited (∼107 M−1s−1) one can
calculate the ADP-off-rate (k-AD=96 s
−1). Reducing
the temperature to 12 °C reduced the measured KAD
to 5 μMand thus also the calculated ADP off-rate (50
s−1). At higher ATP concentration (200 μM) the
fluorescence change of the ATP-induced dissociation
of BMS1-actin, in the absence of ADP, can be fitted to
a double exponential and both kobs values decreased
with increasing ADP concentrations. Plotting the
kobs values versus the ADP-concentration (Figure
6(b)) yielded KAD values of 6.8(±1.7) μM (fast phase)
and 6.6 μM(±1.9) μM (slow phase), indicating that
the kobs of both phases are inhibited by ADP.
The temperature dependences of these two phases
are measured at very high ATP concentrations
([MgATP]=16 mM) in order to define the rate of
ADP release. The ATP-induced dissociation of the
acto–BMS1 complex in the presence of saturating
ADP concentrations (150 μM) is biphasic with a fast
kobs=94 s
−1 (ΔF 55%) and a slow kobs=9.6 s
−1 (ΔF
10%) at 20 °C (see Figure 7(a)). According to the
model depicted in Scheme 2, these two processes are
due to the presence of two actomyosin complexes
with ADP bound in solution, A·M'·D and A·M·D.
The fast phase measured here (94 s−1) is due to the
A·M'·D complex and corresponds well with the
calculated ADP off-rate (96 s−1) and, according toScheme 2 represents k-ADP. The other complex,
A·M·D, is responsible for the slow phase observed
here and, according to Scheme 2, represents the rate-
limiting step of ADP-release (k+αD= 9.6 s
−1).
Between 12 °C–25 °C the temperature dependences
of these observed fast and slow rates are almost
identical (see Figure 6(b)) with similar activation
energy values Ea=106 kJ (fast phase) and 98 kJ (slow
phase). The ratio of amplitudes of the two phases,
Afast:Aslow had a small dependence on the tempera-
ture with Af:As=6.3 at 12 °C and 5.1 at 25 °C.
The small thermodynamic coupling (KAD/KD)
between actin and ADP binding to BMS1 (KAD/
KD=4.8) can be validated by measuring the affinity
of S1 for actin in the presence and absence of ADP
(KDA/KA). Phalloidin-stabilised pyr-actin (15 nM)
incubated with various concentrations of BMS1 were
mixed with ATP (10 μM), and the amplitude of the
dissociation reaction was used to estimate the
fraction of actin bound to BMS1. Without ADP
present, kobs remained constant at all S1 concentra-
tions (kobs=19 s
−1) and the amplitude increased
hyperbolically with [BMS1]. In the presence of
250 μM ADP, the value for kobs was reduced
(15 s−1) and the amplitudes increased hyperbolically
with [S1] (see Figure 8). In the absence of ADP the
best fit to the titration gave a KA∼4–7 nM, whereas
in the presence of ADP the best fit yielded a KDA of
37 nM. Thus, ADP reduced the affinity of S1 for actin
by about fivefold (KDA/KA=37/7=5.2), which is
similar to the reduction in ADP affinity for S1 caused
by actin (KAD/KD=4.8).
Using MHC-II-1 myosin S1 from pig soleus
muscle (PSS1) very similar results were obtained
and these are summarised in Tables 1 and 2. The
ATP-induced dissociation of acto–PSS1 was biphasic
at high ATP with a fast phase (kmax=800–900 s
−1)
and a slow phase (kmax=67 s
−1), and a relative ratio
Afast:Aslow=4.8 (data not shown). This yields a value
for Kα=4.8, and together with the measured value
for k+α=67 s
−1 gives k-α=14 s
−1 (Table 2). In the
presence of ADP (0–200 μM) the ATP-induced
dissociation of acto–PSS1 also gave fluorescence
Figure 4. Displacement of ADP from BMS1-ADP by
addition of excess ATP. (a) and (b) Protein fluorescence
changes observed on mixing 200 μM ATP with 1.0 μM
BMS1 and 0.4 μM ADP. Comparison of the sum of two
exponentials (a) or three exponentials (b) shows that the
data fit best to a sum of three exponentials. The measured
values of the kobs in (b) were 68 s
−1 (fast phase, ΔF +8.9%),
9.6 s−1 (medium phase,ΔF +2.2%) and 0.9 s−1 (slow phase,
ΔF +6%), respectively. (c) Dependence of the relative
amplitudes of the three exponentials on ADP concentra-
tion. The data are fitted to hyperbolae with a Kd of 2.6 μM
(fast phase, ▪), 3.0 μM (medium phase, •) and 3.0 μM(slow phase, ▴). Figure 5. ATP-induced dissociation of pyr-acto–BMS1.
(a) The pyrene fluorescence changes observed on mixing
0.5 μM BMS1 with 200 μMATP at 20 °C. The best-fit double
exponential is superimposed with kobs=278 s
−1 (ΔF +77%)
and 58 s−1 (ΔF +10%) for the fast and slow phase,
respectively. (b) Dependence of kobs on [ATP]. At high
ATP-concentrations, kobs saturates at ∼1100 s−1 for the fast
phase and remains constant at 56(±13) s−1 for the slow
phase. (c) At low [ATP] the data of the fast phase fit a
straight line with slope (K1k+2)=1.23×10
6 M−1s−1.
1190 Bovine Masseter Myosintransients that fitted a single exponential at low ATP
concentrations (b100 μM) and a double exponential
at high ATP concentrations (data not shown) and a
KAD of 15 μM. At very high ATP concentrations
(4 mM MgATP) the ATP-induced dissociation of the
acto–PSS1 complex in the presence of saturatingADP concentrations (50 μM) is also biphasic with a
fast rate kobs,f=48 s
−1 and a slow phase kobs,s=6.5 s
−1
at 20 °C. The ratio of the two amplitudes Afast:Aslow
is 6.5 (20 °C) and represents KαD (see Table 2).Discussion
This paper set out to reexamine and extend the
kinetic analysis of the bovine MHC-II-1 isoform of
myosin found in slow skeletal muscle and the
Figure 6. ATP-induced dissociation of pyr-acto–BMS1
in the presence of ADP. 0.25 μM phalloidin-stabilized
pyrene-labelled actin was incubated with an equimolar
amount of BMS1 before mixing with variable concentra-
tions of ADP and 50 μM ATP (a) or 200 μM ATP (b). The
data could be fitted against a single exponential (a) or a
double exponential (b) and the resulting kobs were fitted
to a hyperbola, resulting in an apparent affinity (KAD)
for ADP (a) KAD=9.6(±1.4) μM (20 °C) and (b) KAD=
6.8(±1.7) μM (▪, fast phase) and KAD=6.6(±1.9) μM (•,slow phase).
Figure 7. ATP-induced dissociation of BMS1-actin in
the presence of ADP. (a) Pyrene fluorescence changes
observed on mixing 16 mMMgATP with 1 μM BMS1-actin
in the presence of 150 μM ADP at 20 °C. The best-fit
double exponential is superimposed with kobs=94 s
−1
(ΔF +55%) and 9.6 s−1 (ΔF +10%) for the fast and slow
phase, respectively. (b) Temperature dependence of ATP-
induced dissociation of BMS1-actin in the presence of ADP
with kobs (fast (▪) and slow (•) phase) as a function oftemperature. From the slope the activation energy can be
calculated. Ea=106 kJmol−1 and 98 kJmol
−1 for the fast and
the slow phase, respectively.
1191Bovine Masseter Myosinventricle of cardiac muscle. Bovine masseter muscle
fibres were successfully used to isolate the S1 cons-
truct (BMS1) of bovine MHC-II-1 myosin. Compar-
ison of the kinetic parameters of BMS1 and the S1
construct isolated from the left ventricle of bovine
cardiac tissue (BCS1),10,11 which is 100% MHC-II-1
and has the same light chain content, shows that
the results agree reasonably well with each other
(Tables 1 and 2). The two parameters that deviate
significantly between BMS1 and BCS1 are discussed
below.
The ATP hydrolysis rate constant reported here is
almost tenfold slower than that reported.12 The
previously reported rate constant was based on the
assumption that when ATP binds to S1, the
maximum rate of the fluorescence change represents
k+3+k-3 (Scheme 1), in analogy with measurements
for fast myosin S1.20,21 However, the quench flow
data reported here show that k+3+k-3 defines the
medium phase observed in the stopped flowmeasurements and the maximum observed rate
constant of the medium phase is k+3+k-3=19 s
−1,
whereas the fast phase represents k+2. The ATP
hydrolysis step of BMS1 is much slower than that of
fast skeletal S1 from rabbit (k+3+k-3=131 s
−1) but it is
similar to the slow skeletal myosin II, MHC-II-1
from rabbit soleus (22 s−1)9 and pig MHC-II-1
(24.5 s−1).24 It may therefore be a general feature of
slow myosin II isoforms. The role of this reduced
ATP hydrolysis rate for MHC-II-1 could be related
to the slow ADP-release rates also observed for
MHC-II-1. A slow ADP-release rate increases the
time myosin is bound to actin (i.e. enhances the duty
ratio). MHC-II-1 can compensate for this by a slow
hydrolysis step thereby maintaining the low duty
ratio typical of striated muscle myosins.
The affinity of ADP for BMS1 in the absence of
actin (KD=2 μM) is weaker than the value reported
for BCS1 (KD=0.33 μM) when the interaction of ATP
and ADP with BCS1 was investigated.11 Due to
aggregation problems in the BCS1 work, the inter-
action with ATP was reinvestigated a year later12
but as far as we are aware, the interaction with ADP
Scheme 2. Proposed reaction scheme for the interaction of BMS1 with nucleotides (T, ATP; D, ADP) in the presence of
actin as proposed for myosin I (A represents actin and M is myosin S1).44
1192 Bovine Masseter Myosinhas never been re-examined and this may therefore
account for the discrepancy between the KD values.
Table 1 shows that the k+6 values measured for
BMS1
and BCS1 differ two- to threefold (k+6=0.9–1.4 s
−1
and 0.5 s−1, respectively) while the values for k-6/K7
are fairly similar (1.24×106 M−1s−1 and 1.4×106
M−1s−1). The revised KD value for bovine MHC-II-1
S1 has implications for the thermodynamic coupling
constant between the affinity of myosin for ADP and
actin, KAD/KD (see below).
Comparison of fast and slow muscle myosin II
isoforms shows that in the absence of actin, most
kinetic parameters are quite similar (Table 1). The
major exception is the ATP-hydrolysis rate (k+3+k-3),
which is about tenfold slower for the slowMHC-II-1
S1 isoforms compared to rabbit psoas S1. The ADP
dissociation rate constant (k+6) is very similar for all
slow isoforms (k+6 0.5–0.9 s
−1) and about twofold
slower than the ADP dissociation rate constant of
fast skeletal S1 (k+6=1.4 s
−1). The ADP associationFigure 8. Titration of actin with BMS1. 30 nM phalloi-
din-stabilised pyrene-labelled actin was incubated with
various amounts of BMS1 before mixing with 500 μM ATP
in the presence of 500 μM ADP (▪) or with 20 μM ATPwithout ADP (□). In both cases the reaction was well
described by a single exponential and the amplitude
increased with increasing [BMS1]. The best fit to the
quadratic equation describing the binding isotherm (see
Materials and Methods) gave a Kd of 7 nM and 37 nM in
the absence and presence of ADP, respectively (concentra-
tions used here are before mixing).rate constant (k-6/K7) is similar for all slow isoforms.
The different estimates of ADP binding and release
result in a surprisingly wide range of values for the
ADP-affinity for S1 isoforms listed from 0.4 μM
(rabbit soleus) to 2 μM (bovine masseter). However,
these KD values are well defined by both the ratio of
rate constants (Figure 2) and the amplitude titration
data (Figure 4), suggesting that this parameter does
vary across the series of isoforms.
The data in the presence of actin (Table 2) indicate
that the affinity of S1 for actin in the presence (KDA)
and absence (KA) of ADP shows a sursprisingly large
variation within the group of slow isoforms with a
tenfold difference in KA value of bovine masseter
and rabbit soleus and an even larger difference in
KDA value. However, despite these differences in
individual equilibrium constants, the slow isoforms
show a similar range of values for their ther-
modynamical coupling constants (KAD/KD and
KDA/KA). The slow isoforms show ratios of 3–20,
all lower than the value for fast rabbit isoforms (30–
60) and at the lower end similar to smooth muscle
myosin (4–7)25,26 and non-muscle isoforms (∼1–5).
Table 2 shows the parameters that control the ATP
induced dissociation of acto–S1 vary relatively little
for the fast and slow muscle isoforms listed (K1k+2'
and k+2' vary less than twofold). The major
difference is that all of the slow isoforms show a
two-phase ATP-induced dissociation of acto–S1
whereas the fast muscle protein shows a single
phase. Siemankowski & White10 stated that the
ATP-induced dissociation of actoBCS1 (in the pre-
sence or absence of ADP) could not be fitted un-
ambiguously to a single exponential, suggesting that
it too has two components. Additional indications of
two phases comes from data measured for other
slow MHC-II-1 isoforms of the chicken, from slow
skeletal, cardiac, and smooth muscle27 which all
show the presence of an additional small slow
phase. Thus, a biphasic reaction for ATP-induced
dissociation of acto–S1 appears to be common for
slow muscle myosin isoforms. ATP-induced bipha-
sic dissociation of acto–S1 has also been reported for
a some class I mammalian myosins and non-muscle
myosin II.26 The biphasic transient has been inter-
preted in terms of scheme II in which a fraction of
Table 2. Comparison of rate and equilibrium dissociation constants for the head fragments of different myosins in the
presence of actin at 20 °C and 100 mM KCl (pH 7.0) unless indicated otherwise
Parameter S1 (bovine)a masseter S1 (rabbit)b skeletal S1 (bovine)c cardiac S1(rabbit)e soleus S1 (pig)a soleus
K1k+2' (10
6 M−1s−1) 1.24 2.4 2.0 1.72 1.55
k+2'(s
−1) 1220 902f N500 1019 730h
k+α (s
−1) 56 – – 45 67h
Kα 7.7 – – 6.2 4.8
h
KD (μM) 2 2 0.33
d 0.41 0.5–1.4
KAD (μM) 9.6 120 6.7 11.3 15
k-ADP (s
−1) 94 – 65 58 48
KαD 5.3 – – 0.26
g 6.5
k+αD (s
−1) 9.6 – – 15g 8
KA (nM) 7 33 6.3 74 –
KDA (nM) 37 1000 100 1400 –
KAD/KD 4.8 30–60 15–20 21 11–30
KDA/KA 5.3 30 16 19 –
a This study.
b From Ritchie et al.45
c From Siemankowski & White.10
d From Flamig & Cusanovich11 at 15 °C.
e Rabbit soleus S1 in 30 mM KCl, except KD.
9
f From Iorga et al.9 at 30 mMKCl. Rabbit psoas S1 k+2 was calculated using the reported value at 12 °C and the temperature dependence
of the value over the range 5 °C –15 °C.
g At 10 °C.
h At 12 °C.
1193Bovine Masseter Myosinthe acto–S1 must isomerise before nucleotide can
bind.
The work presented here also confirms the
complex nature of the ADP release from acto–S1
reported for soleus S1. It is not simply that ADP
release is much slower for this group of myosins
than for the fast muscle myosin but there is clear
evidence for several A.M–ADP complexes. We show
here evidence for two complexes with ADP with an
equilibrium constant between them (KαD) of 5.3 and
rate constants of ADP release of 94 (k-ADP) and 9.6
(k+αD) s
−1. Similar behavior is seen with the pig
soleus (Table 2) and rabbit soleus (Table 3) but with
variation across the three slow isoforms particularly
in the value of KαD. The data with rabbit soleus
provided evidence for a third AMD complex and by
analogy we might expect a rapid collision complex
between ADP and acto–S1 not characterised here.
The value of the ADP release rate constant (k-ADP)
has been assigned to the event during the actin-
attached part of the ATPase cycle, which limits the
maximum shortening velocity (V0) of a muscle fibre.
The velocities of contraction are best characterised at
12 °C (0.17 M ionic strength) and the published
values of V0 for the three slow muscle isoforms are
listed in Table 3 along with the values of the ADPTable 3. The measured and calculated kinetic parameters for
MHC1
V0 (μm s
−1
0.5 sm−1 kmin,10 (s
−1) kmin,5 (s
−1) k-ADP (s
−1) k+αD (s
−1)
Cow 0.27a 27 54 27 3.5
Pig 0.17b 17 34 36 5.7
Rabbitc 0.67d 67 134 63 15
a From Tonilo et al.13
b From Tonilo et al.15
c Kinetic data from Iorga et al.9
d From Pellegrino et al.46release constant at 12 °C. The maximum unloaded
shortening velocity of muscle fibres (V0) of bovine
masseter is 0.27 μm s−1 at 12 °C.13 From this, one can
estimate the minimum value of the rate constant that
limits the detachment of the cross-bridge (kmin)
using the relationship:
kmin ¼ V0d
with V0=maximum sliding velocity (nm s
−1) and
d=working stroke (nm).8 Depending on the size of
the working stroke, kmin is 54 s
−1 (d=5 nm) or 27 s−1
(d=10 nm) for bovine masseter MHC-II-1. From
Table 3 one can see that at 12 °C k-ADP is 27 s
−1,
which is close to the calculated kmin value. The data
from the pig shows a similar correlation between
kmin and k-ADP, as does the previously published
data from rabbit.9 For all three MHC-II-1 isoforms
the measured values of k+αD are much slower than
the calculated kmin, indicating that this isomerisation
step cannot be part of the main pathway of the un-
loaded cross-bridge cycle but represents a branched
pathway that could become significant if the motor
is contracting under loaded conditions. The velocity
measurements are, by definition, made under zero
load and the isomerisations controlling the ADPthree MHC-II-I isoforms at 12 °C, 100 mM KCl (pH 7)
k-αD (s
−1) k+α (s
−1) k-α (s
−1) Kα KαD KAD (μM) KADP (μM)
0.55 31 5.3 5.8 6.3 4.9 5.7
0.79 70 14.6 4.8 7.2 15 17.1
7.9 40 9.5 4.2 1.25 6 3.3
1194 Bovine Masseter Myosinrelease steps are events which are potentially sen-
sitive to the load on the actomyosin cross-bridge.
The evidence that ADP release is load-dependent
has been discussed in general terms by Nyitrai &
Geeves28 and specifically for the rabbit MHC-II-1
isoform by Iorga et al.9 The data for bovine and
porcine isoforms are shown here to be similar to the
rabbit isoform and a similar interpretation is
possible. Briefly, there is substantial evidence from
single-molecule mechanical measurements29–32 and
electron micrographs of S1 decorated actin fila-
ments17–19 that, for a range of non-muscle myosins
and the smooth-muscle myosin there is a load-
dependent structural change after the major force
generating event. The force-generating event is
associated with phosphate release and the second
structural change is probably associated with ADP
release. More recent studies with improved laser
traps33 and X-ray scattering from S1-decorated,
orientated actin filaments16 have extended these
observations to striated muscle myosins. The laser
trap observed a∼1 nmmovement of the lever arm in
the second step for the rat MHC-II-1 isoform and the
rate constant we expect for the event limiting ADP
release is compatible with the lifetimes measured in
the laser trap. The X-ray data report a similar sized
movement of the lever arm on binding/release of
ADP for the rabbit slow muscle S1. Together, the
structural mechanical and biochemical kinetic stu-
dies support the hypothesis of a load dependent
isomerisation of the actomyosin complex required to
allow release of ADP.
The results presented here on the protein isomer-
isations that limit ADP release from the actomyosin
of slow muscle may provide some insight into why,
despite a tight affinity for ADP, slow muscles are
more resistant to fatigue than fast muscles, or at least
the part of fatigue associated with ADP build up.
Fatigue is classically defined from studies of the
effect of prolonged stimulation on the isometric
tension of intact muscle fibres. The complete ex-
planation of the loss of tension remains to be defined
but any build up of ADP is likely to result in the
enhancement of the lifetime of strongly boundA.M.–
ADP states as ADP competes with ATP induced
detachment of the cross-bridge. The increased life-
time will increase steady-state tension as is seen on
addition of ADP to skinned muscle fibres.34–36 Thus,
ADP build up may compensate for other effects of
fatigue which tend to reduce tension and the
compensatory effect will be greater in slow than in
fast muscle fibres.
The effect of ADP on velocity is different; the
evidence is for a slowing of maximal shortening
velocity in skinned muscle fibres.34,37 In a fast
muscle the velocity is limited by the rate of ATP-
induced dissociation of actin from A.M., and ADP
competes with ATP for binding to the nucleotide
pocket.38 The net rate constant for actin detachment
is defined by:
kdetach ¼ K1kþ2½ATP=ð1þ K1½ATP þ ½ADP=KADÞThus, atmMATP concentrations, ADP of the order of
the KAD (∼100 μM) can produce a significant
inhibition of the detachment rate constant. For slow
muscle the detachment of myosin from actin is
limited not by the ATP induced reaction but by the
slower isomerisation preceding ADP release, con-
trolled by k-ADP (Table 3 gives this as 27 s
−1 for
masseter at 12 °C). The following ATP-induced
dissociation of AM remains much faster than this
(∼1000 s−1 at mM ATP concentrations, in fact the K1,
and k+2 values are similar for fast and slow myosin
isoforms; see Table 2) and the velocity will only be
slowed once the ADP competition effect reduces
kdetach to b100 s
−1 (equation (7)). This requires the
ADP concentration to be many times the KAD value
or for the ATP concentration to fall to ∼100 μM.
In summary we have shown that the MHC-II-1
isoforms isolated from slow skeletal muscles from
the cow and the pig are similar in general properties
to MHC-II-1 isolated from bovine cardiac tissue and
to the MHC-II-1 of the rabbit and these are quite
distinct from the MHC-II-2 isoforms. Of significance
is the slow ATP-hydrolysis rate, the low thermo-
dynamic coupling between ADP and actin binding,
the slow rates of ADP release (which are of the
correct size to limit the maximum shortening
velocity) and multiple actomyosin ADP complexes.
Nucleotide access to and release from the binding
site requires relatively slow isomerisations and these
may be load-dependent. These properties are
distinct from the fast muscle MHC-II-2 isoforms
and similar to smooth and some non-muscle myosin
isoforms, e.g. mammalian myosins 1b and 1c, and
non-muscle myosin II. However, unlike the non-
muscle isoforms, the MHC-II-1 isoforms have a low
duty ratio and can produce relatively rapid move-
ment in motility assays or in muscle fibres. These
parameters suggest that slow muscle myosin iso-
forms may form a distinct functional group from the
fast muscle isoforms and the slower group which we
have called the strain-sensors; non-muscle myosins
particularly a sub-set of class I myosins (myo1b and
1c) that appear to operate less as transport motors
than as load-bearing and strain-sensing molecules.
Slow muscle myosin, like fast muscle myosin, is
required for movement but also has an additional
role in efficient load bearing in postural muscles.
Thus, the molecular properties of the MHC-II-1
motor are consistent with its physiological role.Materials and Methods
Proteins
MHC-II-1 myosin was purified from bovine masseter
muscle fibres that had been frozen in liquid nitrogen prior
to storage at −80 °C. Purification was based on the method
described.39 Briefly, the tissue (40 g) was homogenized in
ice-cold Guba-Straub buffer (pH 6.6) and the suspension
was stirred for 30 min. After centrifugation, the super-
natant was diluted tenfold with water. The precipitated
protein was collected by centrifugation. The pellet was
1195Bovine Masseter Myosintaken up in 3M KCl and ice-cold water was then added to
precipitate the myosin and the protein was collected by
centrifugation. This procedure was repeated three times
and the pellet was then taken up in a small amount of 3M
KCl and then adjusted to 125 mM KCl, 10 mM KPi, 2 mM
EDTA, 4 mM dithiothreitol (DTT, final concentrations) for
digestion. Subfragment 1 (BMS1) was prepared by diges-
ting myosin using chymotrypsin using the method
described.40 The soluble BMS1 protein was separated
from the non-digested myosin and the insoluble myosin
tails by centrifugation and purified over a Q-Sepharose
column in 50 mM imidazole (pH 7) with a linear gradient
from 0–500 mM KCl. The fractions containing BMS1 were
pooled and dialysed into 10 mM KPi buffer (pH 7.5) and
typical yields were around 140 mg of protein. Figure 1
shows the isolated myosin with two light chains and the
purified BMS1 with only one light chain bound. The gel
suggests only one isoform of each light chain and the
molecular mass of the essential light chain is consistent
with this being the MLC-1b/v isoform expected in slow
skeletal and ventricle muscle. For myosin S1, isolated from
pig soleus muscle, a similar procedure was followed to
isolate the protein and from 58 g of tissue about 70 mg of
pig soleus S1 (PSS1) was obtained. After dialysis, BMS1 and
PSS1 were lyophilized in the presence of 1% (w/v) sucrose
and stored at −20 °C. Prior to use, BMS1 or PSS1 was
dialyzed into 20 mM Mops, 30 mM KCl, 5 mM MgCl2,
1 mM sodium azide and remained stable in solution for
several days. Rabbit skeletal muscle actin was prepared
according to methods described41 and, when necessary,
labelled with pyrene at Cys374.42
ATPase assay
ATP-ase activity was measured using an NADH-
coupled assay at 20 °C in buffer containing 20 mM Mops
(pH 7), 5 mMMgCl2, 30 mM KCl, 1 mM ATP, 40 units/ml
of lactate dehydrogenase, 200 units/ml of pyruvate
kinase, 1 mM phosphoenolpyruvate, and 200 μM
NADH. Changes inA340 (ε=6220M
−1cm−1) were followed
using a UV-VIS spectrophotometer. The basal Mg2+-
ATPase activity of bovine masseter myosin S1 (0.012 s−1)
agrees well with the value reported (0.017 s−1) for bovine
cardiac myosin S1 isolated from bovine cardiac left
ventricle.12 In the presence of 50 μM actin the Mg2+-
ATPase activity of BMS1 increasedmore than tenfold (0.182
s−1) and the ATP-ase rate was linearly related to the actin
concentration over the range of 0–50 μM. (Not shown).
Transient kinetics
All kinetic experiments were performed at 20 °C in
20 mMMops, 100 mM KCl, 5 mMMgCl2 and 1 mM azide
(pH 7), unless indicated otherwise. Allmeasurementswere
done with a High-Tech Scientific SF-61 DX2 stopped-flow
system. Pyrene actin fluorescence was excited at 365 nm
and emission was detected after passing through a
KV389 nm cut-off filter (Schott, Mainz, Germany). Trypto-
phan fluorescence was excited at 295 nm and observed
through a WG320 filter. The stated concentrations of re-
actants are those after mixing in the stopped-flow obser-
vation cell (“post”) unless indicated otherwise. Stopped-
flow data were analysed using the software provided by
Hi-Tech (KinetAsyst) and the Origin software (Microcal).
Without actin present, the kinetics of S1 (either BMS1 or
PSS1; M) with nucleotide (T,ATP; D,ADP) were interpreted
based on the seven-step model described by Bagshaw
et al.,43 where k+i and k-i are the forward and reverse rateconstants and Ki (k+i/k-i) represents the equilibrium
constant of the reaction (Scheme 1).
In the presence of actin the kinetics of the interaction
of S1 with nucleotide were based on the model proposed
for myo1b26,44 and is depicted in Scheme 2. In this model,
AM exists in two conformations in the absence of nucleo-
tide (A.M and A.M', equilibrium defined by Kα=k+α/k-α)
and in the presence of ADP (A.M.D and A.M'.D, equi-
librium defined by KαD=k+αD/ k-αD). In the AM' state, the
nucleotide can exchange with the solvent (“open” con-
formation) but not in the AM state (“closed” conforma-
tion). Conversion of M to M' requires opening of the
nucleotide binding pocket. The data presented here and
summarised in Tables 1 and 2 allow assignment of all the
rate and equilibrium constants of Scheme 2. The assign-
ment of the constants to the data is summarized here.
In the absence of ADP, high ATP concentrations induce
the dissociation of actin from S1 in two phases. The fast
phase represents dissociation from A.M' with:
kobs;fast ¼ K1kþ2½ATP=ð1þ K1½ATPÞ ð1Þ
The slow phase is limited by the isomerisation from
A.M to A.M' with the maximum value of kobs,slow=k+α.
The ratio of the amplitudes of the fast and the slow phase
of the ATP-induced dissociation defines the equilibrium
constant between the two conformations in solution and
since Kα=k+α/k-α, k-α can be determined:
Afast=Aslow ¼ ½A:M V=½A:M ¼ Ka ð2Þ
For fast myosin S1, such as skS1 and psoS1, KαNN1 and
only a single phase is observed.
For slow myosin S1, in the presence of ADP, the overall
dissociation constant of ADP for the actin-S1 complex
(KAD) is defined by equation (3):
KAD ¼ KADPdKaD=ð1þ KaDÞ ð3Þ
where KADP is the dissociation constant for ADP from
A.M' and KαD the equilibrium constant between AM'D
and AMD. If the binding of ADP is a rapid equilibrium
event, controlled by KADP, ADP and ATP compete effect-
ively for binding to AM and the observed rate constant
kobs is defined by equation (4):
kobs ¼ k0=ð1þ ½ADP=KADÞ ð4Þ
where k0 is the observed rate constant of ATP-induced
actin–S1 dissociation in the absence of ADP and defined
by equation (1). To titrate both A.M complexes to A.M.D,
actin–S1 was pre-equilibrated with a range of ADP
concentrations before adding excess ATP. ATP-induced
dissociation of actin from A.M.D occurs via the inter-
mediate A.M'.D and A.M' and is limited by k+αD. If k+α
and k+αD differ by more than a factor of 3, then both fast
and slow amplitudes seen at zero ADP are reduced as
ADP is increased and replaced by a new phase with
kobs=k+αD (this is the case for
BMS1). The effect of ADP on
the amplitude of the fast phase of ATP-induced dissocia-
tion of actin-S1 was analysed according to:
Ampfast ¼ Amp0=ð1þ ½ADP=KADÞ þ C ð5Þ
where Ampfast represents the observed amplitude of the
fast phase of the reaction, Amp0 is the amplitude at zero
ADP concentration, [ADP] is the concentration of ADP
before mixing, KAD is the dissociation equilibrium
constant of ADP for actin–S1, and C is the end point.
The end point of the reaction defined by Cwas defined by
the fluorescence at infinite high ADP concentrations.
1196 Bovine Masseter MyosinAmplitude is calculated as a percentage of the end point of
the reaction, according to:
Amplitude ¼ ðDF=Flt Þ  100 ð6Þ
Where amplitude, expressed as %, equals the change in
fluorescence observed during the reaction (ΔF) divided by
the fluorescence at the end point of the reaction (Ft
∞),
multiplied by 100.Quenched-flow experiments
The quenched-flow experiments were carried out with a
Hi-Tech RQF-63 using a buffer containing 100 mM KCl,
5 mM MgCl2, 20 mM Mops (pH 7.0). BMS1 (5 μM) was
mixed with excess ATP (50 μM) and incubated at 20 °C for
desired time intervals (up to 350 ms). The reaction was
quenched by the addition of an equal volume of 6.25%
(w/v) trichloroacetic acid (TCA). After neutralisation with
NaOH and a clarification spin at 3000g for 5 min, the
samples were diluted 1:10 with the fast protein liquid
chromatography running buffer containing 125 mM KPi
(pH 5.5). The separation of ADP and ATP was carried out
on a fast protein liquid chromatography (FPLC) system
(Amersham Biosciences) using a Hypersil ODS (3 μm)
column and an isocratic flow. Integration of the peak areas
provided the ratio of ADP and ATP at each time point. The
ratio of the ADP to the total nucleotide concentration at
each given time point was then used to calculate the
hydrolysis rate of the myosin. The amount of irreversibly
bound ATP to BMS1 at the end of the burst was determined
by quenching the reaction into a 100 mM KCl, 20 mM
Mops, 5 mM MgATP buffer containing hexokinase
(2 μg /μl) and glucose (1 mM) after 1 s and then adding
6.5% TCA after a further 1 s. In controls this treatment
hydrolysed any free ATP to ADP. HPLC analysis of the
reaction mixture gives information about the amount of
ATP bound to S1 at the end of the burst phase.Acknowledgements
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